Health Sciences researchers awarded nearly $20M in federal funding
Of this 20M total funding, 6M in awards went to the following Department of Oncology Researchers.
Hira Mian and Gregory Pond
A Phase III Non-Inferiority Randomized Controlled Trial (RCT) of Fixed-Duration Daratumumab Versus Continuous Daratumumab Among Transplant Ineligible Older Adults with Newly-Diagnosed Multiple Myeloma ($3,056,172)
Jonathan Bramson, (Department of Medicine), Hira Mian, Amaris Balitsky and Courtney Coschi
The TACtful Trial: A first-in-human multi-centre trial of BCMA specific T-cell antigen coupler infusion, generated from cryopreserved G-CSF-mobilized peripheral blood, in patients with relapsed and refractory multiple myeloma ($3,056,176)
Read more at Daily News.
Funding
